logo
Search orAI Icon𝛼SK
ENTITY

Mira Pharmaceuticals (MIRA US)

26
Analysis
Health Care • United States
Mira Pharmaceuticals, Inc. operates as a biotech company. The Company develops prescription drug to target the CB1 and CB2 receptors for chronic pain and anxiety without the impurities of marijuana or its side effects such as increased appetite and paranoia. Mira Pharmaceuticals serves customers worldwide.
more
bullish•Mira Pharmaceuticals
•23 Apr 2025 23:00•Issuer-paid

MIRA: Large Market Potential Opens Up

MIRA Pharmaceuticals(MIRA) Company Sponsored Research Report

Logo
Share
bullish•Mira Pharmaceuticals
•17 Apr 2025 00:00•Issuer-paid

MIRA: Tests Show Positive Results

MIRA Pharmaceuticals(MIRA) Company Sponsored Research Report

Logo
Share
bullish•Mira Pharmaceuticals
•01 Apr 2025 23:00•Issuer-paid

MIRA: Subject Enrollment Moves Trial Forward

MIRA Pharmaceuticals(MIRA) Company Sponsored Research Report

Logo
Share
bullish•Mira Pharmaceuticals
•24 Mar 2025 23:00•Issuer-paid

MIRA: Expands Pipeline and Increases Capital

MIRA Pharmaceuticals(MIRA) Company Sponsored Research Report

Logo
Share
bullish•Mira Pharmaceuticals
•14 Mar 2025 23:00•Issuer-paid

MIRA: Pain Management Options Expand

MIRA Pharmaceuticals(MIRA) Company Sponsored Research Report

Logo
Share

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.59.7

x